Literature DB >> 3766273

Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin.

H W Ruelius, S K Kirkman, E M Young, F W Janssen.   

Abstract

Hydrolysis and rearrangement (isomerization by acyl migration) of oxaprozin glucuronide are greatly accelerated by plasma and human serum albumin. Albumin accounts for all the hydrolytic activity in plasma and no esterase is involved. The isomeric esters formed by rearrangement are also good substrates for the hydrolysis reaction. Another reaction between oxaprozin glucuronide and albumin leads to covalent binding of the aglycone. Similar reactions leading to covalent binding have been described for other acyl glucuronides by several investigators. In the case of oxaprozin, there is little or no potential for biological significance of covalent binding because the reaction is almost entirely inhibited by low concentrations of the drug. All three reactions are pH dependent but not to the same extent. They can be considered to be transacylations to the hydroxyl ion (hydrolysis), to a different OH-group of the glucuronic acid moiety (rearrangement) or to a nucleophilic group on the albumin molecule (covalent binding). All three reactions are greatly inhibited by the same compounds suggesting a common reaction site. This site has certain features in common with the indole or benzodiazepine binding site of human serum albumin. A scheme is proposed in which the first step is reversible binding of the acyl glucuronide to this site in analogy to the known reversible binding of reactive esters (such as p-nitrophenyl acetate) to the same site. All three reactions are inhibited by compounds such as naproxen and decanoic acid which are known to also inhibit the acylation of albumin by reactive esters and the reversible binding of benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3766273     DOI: 10.1007/978-1-4684-5134-4_42

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  Reaction of acyl glucuronides with insulin in vitro: identification of an imine mechanism by electrospray ionization mass spectrometry.

Authors:  J H Liu; C D Marquez; S T Weintraub; P C Smith
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

2.  Stereoselective binding properties of naproxen glucuronide diastereomers to proteins.

Authors:  A Bischer; P Zia-Amirhosseini; M Iwaki; A F McDonagh; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1995-08

3.  Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients.

Authors:  Thomas G Hammond; Xiaoli Meng; Rosalind E Jenkins; James L Maggs; Anahi Santoyo Castelazo; Sophie L Regan; Stuart N L Bennett; Caroline J Earnshaw; Guruprasad P Aithal; Ira Pande; J Gerry Kenna; Andrew V Stachulski; B Kevin Park; Dominic P Williams
Journal:  J Pharmacol Exp Ther       Date:  2014-06-05       Impact factor: 4.030

4.  Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry.

Authors:  A Ding; J C Ojingwa; A F McDonagh; A L Burlingame; L Z Benet
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma.

Authors:  J C Ojingwa; H Spahn-Langguth; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1994-02

Review 6.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

7.  Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro.

Authors:  A Munafo; A F McDonagh; P C Smith; L Z Benet
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

8.  Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic?

Authors:  H F Liu; M Vincent-Viry; M M Galteau; R Guéguen; J Magdalou; A Nicolas; P Leroy; G Siest
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.